Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2014
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trialPhilippe Gallien, Gérard Amarenco, Nicolas Benoit, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumptionFabrice Lainé, Claude Bendavid, Romain Moirand, et al.
The Journal of Infection|June 27, 2013
The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trialJean-Marc Chapplain, Eric Bellissant, Dominique Guyader, et al.
Clinical Transplantation|April 27, 2011
Efficacy and safety of Celsior preservation fluid in liver transplantation: one-year follow up of a prospective, multicenter, non-randomized studyKarim Boudjema, Stéphane Grandadam, Philippe Compagnon, et al.
Lancet (London, England)|August 28, 2007
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trialDjillali Annane, Philippe Vignon, Alain Renault, et al.
Hepatology (Baltimore, Md.)|September 30, 2016
Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patientsFabrice Lainé, Marc Ruivard, Véronique Loustaud-Ratti, et al.
Infection Control and Hospital Epidemiology|October 21, 2011
Randomized comparison of 2 protocols to prevent acquisition of methicillin-resistant Staphylococcus aureus: results of a 2-center study involving 500 patientsChristophe Camus, Eric Bellissant, Annick Legras, et al.
AIDS (London, England)|May 6, 2016
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapyFarid Kheloufi, Eric Bellissant, Laurent Cotte, et al.
Fundamental & Clinical Pharmacology|April 18, 2026
Evaluating the Environmental Impact of Clinical Research: A Full Life Cycle Analysis of a French Academic Randomised Clinical TrialClaire Fougerou-Leurent, Louise Forteau, Maëlle Perrot-Loyer, et al.
HIV Clinical Trials|April 15, 2016
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 studyIsabelle Poizot-Martin, Eric Bellissant, Rodolphe Garraffo, et al.
Pageof 3